European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - insulin lispro - diabetes mellitus - drugs used in diabetes - for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. insulin lispro sanofi is also indicated for the initial stabilisation of diabetes mellitus.

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drugs used in diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - dupilumab -

Israel - English - Ministry of Health

sanofi - aventis israel ltd - roxithromycin - film coated tablets - roxithromycin 150 mg - roxithromycin - for the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ent bronchopulmonary, genital and skin manifestations.

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - rasburicase - hyperuricemia - all other therapeutic products - treatment and prophylaxis of acute hyperuricaemia, in order to prevent acute renal failure, in adults, children and adolescents (aged 0 to 17 years) with haematological malignancy with a high tumour burden and at risk of a rapid tumour lysis or shrinkage at initiation of chemotherapy.

European Union - English - EMA (European Medicines Agency)

sanofi b.v. - sevelamer carbonate - hyperphosphatemia; renal dialysis - all other therapeutic products - sevelamer carbonate winthrop is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.sevelamer carbonate winthrop is also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus > 1.78 mmol/l.sevelamer carbonate winthrop should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - riluzole - amyotrophic lateral sclerosis - other nervous system drugs - rilutek is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (als).clinical trials have demonstrated that rilutek extends survival for patients with als.survival was defined as patients who were alive, not intubated for mechanical ventilation and tracheotomy-free.there is no evidence that rilutek exerts a therapeutic effect on motor function, lung function, fasciculations, muscle strength and motor symptoms.rilutek has not been shown to be effective in the late stages of als.safety and efficacy of rilutek has only been studied in als. therefore, rilutek should not be used in patients with any other form of motor-neurone disease.

European Union - English - EMA (European Medicines Agency)

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - enoxaparin sodium - injection - 2000 anti-xa iu (20 mg)/0.2 ml - enoxaparin sodium 2000 iu (20 mg)/0.2 ml

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - enoxaparin sodium - injection - 4000 anti-xa iu (40mg)/0.4 ml - enoxaparin sodium 4000 iu (40mg)/0.4 ml